Mary E. Klotman
CIK: 0002020575
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AMGN
AMGEN INC
Director
Discretionary Trading P&L
Holdings
About Klotman Mary E.
Klotman Mary E. (SEC CIK 0002020575) files insider reports with the SEC as Director of AMGEN INC (AMGN).
Signal8 holds 2 ownership filings by Klotman Mary E., all Form 4s, filed between May 28, 2025 and May 21, 2026. Those filings report 2 transactions, from May 23, 2025 to May 19, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Klotman Mary E.'s filings is in THOUSAND OAKS, CA.
Recent filings by Klotman Mary E.
Other insiders filing for AMGEN INC (AMGN)
- Gibbs David W, Director
- Dittrich Thomas J.W., EVP & CFO
- Khosla Rachna, SVP, Business Development
- Busch Matthew C., VP, Finance & CAO
- ISHRAK OMAR, Director
- HOLLEY CHARLES M, Director